European Journal of Pharmacology 1991: Vol 195 Index

15 Pages·1991·5.1 MB·English

European Journal of Pharmacology, 195 (1991) 417-419 417
© 1991 Elsevier Science Publishers B.V. 0014-/2919 /9$039.5 0
Author index
Aasen, A.J., see Feifel, R. (195) 115 Drozdowicz, D., see Konturek, S.J. (195) 347
Achermann, P., see Borbély, A.A. (195) 11 Drukarch, B., see Van Vliet, B.J. (195) 295
Amon, I., see Konturek, S.J. (195) 347 Duckles, S.P., see Li, Y. (195) 365
Andén, N.-E., see Liljequist, S. (195) 55 Dunant, Y., see Girod, R. (195) 1
Aono, J., Sugawa, M., Koide, T. and Takato, M.
The role of cGMP in the anti-aggregating properties of BY-1949, a Ernsberger, P., see Gomez, R.E. (195) 181
novel dibenzoxazepine derivative (195) 225 Erspamer, V., see Melchiorri, P. (195) 201
Arakawa, C., see Masuda, Y. (195) 323 Espey, M.J., see Downie, J.W. (195) 301
Arita, M., see Hisatome, I. (195) 381 Evans, R.H., see Siarey, R.J. (195) 241
Barnes, J.C. and Roberts, F.F. Falconieri-Erspamer, G., see Melchiorri, P. (195) 201
Central effects of muscarinic agonists and antagonists on hippo- Feifel, R., Rodrigues de Miranda, J.F., Strohmann, C., Tacke, R.,
campal theta rhythm and blood pressure in the anaesthetised rat Aasen, A.J., Mutschler, E. and Lambrecht, G.
(195) 233 Selective labelling of muscarinic M, receptors in calf superior
Barone, P., Palma, V., DeBartolomeis, A., Tedeschi, E., Muscettola, cervical ganglia by [*H]( +)-telenzepine (195) 115
G. and Campanella, G. Feinland, G., see Gomez, R.E. (195) 181
Dopamine D, and D, receptors mediate opposite functions in Fibiger, H.C., see Nomikos, G.G. (195) 63
seizures induced by lithium-pilocarpine (195) 157 Fleming, N.W., Henderson, T.R. and Dretchen, K.L.
Barra, D., see Melchiorri, P. (195) 201 Mechanisms of respiratory failure produced by neostigmine and
Besson, J.-M., see Kayser, V. (195) 37 diisopropyl fluorophosphate (195) 85
Bhattacharyya, B.J., Sokoll, M.D. and Long, J.P.
Effect of (+)-DOI on neuromuscular transmission: a microelec- Gajewski, J.B., see Downie, J.W. (195) 301
trode study (195) 171 Galletti, F., Zheng, W., Gopalakrishnan, M., Rutledge, A. and Trig-
Borbély, A.A. and Achermann, P. gle, D.J.
Ultradian dynamics of sleep after a single dose of benzodiazepine Interactions of analogs of the 1,4-dihydropyridine tiamdipine in
hypnotics (195) 11 cardiac and smooth muscle (195) 125
Brooks, D.P., see Nambi, P. (195) 167 Garlicki, J., see Konturek, S.J. (195) 347
Bruno, M., see Grassi, A. (195) 251 Gillard, N.P., Quirk, K., Ragan, C.I. and McKernan, R.M.
Brzozowski, T., see Konturek, S.J. (195) 347 ['7°I]lodoclonazepam, a specific high affinity radioligand for the
identification of BZ, and BZ, sites in rat brain (195) 407
Campanella, G., see Barone, P. (195) 157 Gilmore, J., see Snyder, D.W. (195) 209
Carlson, J.N., see Glick, S.D. (195) 341 Giovannini, M.G., Lacey, G., Pepeu, G. and Nistri, A.
Chase, T.N., see Marin, C. (195) 19 Release of endogenous glutamate and aspartate from the frog
Chaudhuri, G., see Ross, G. (195) 291 spinal cord in vitro (195) 47
Chicau-Chovet, M., see Sautereau, D. (195) 217 Girod, R., Loctin, F. and Dunant, Y.
Cho, H.L., see Snyder, D.W. (195) 20% Local anaesthetic activity of vesamicol in the electric organ of
Christofi, F.L., Palmer, J.-M. and Wood, J.D. Torpedo (195) 1
Neuropharmacology of the muscarinic antagonist telenzepine in Gitter, S., see Speiser, Z. (195) 75
myenteric ganglia of the guinea-pig small intestine (195) 333 Glick, S.D., Rossman, K., Steindorf, S., Maisonneuve, I.M. and
Chyu, K.-Y., see Ross, G. (195) 291 Carlson, J.N.
Cook, D., see Zhang, H. (195) 27 Effects and aftereffects of ibogaine on morphine self-administra-
Corsi, R., see Melchiorri, P. (195) 201 tion in rats (195) 341
Costa, G., see Massi, M. (195) 245 Glossmann, H., see WOll, E. (195) 399
Cowan, A., see Wheeler-Aceto, H. (195) 411 Gomez, R.E., Ernsberger, P., Feinland, G. and Reis, D.J.
Coyle, J.T., see Yamada, K. (195) 395 Rilmenidine lowers arterial pressure via imidazole receptors in
brainstem Cl area (195) 181
Damsma, G., see Nomikos, G.G. (195) 63 Gopalakrishnan, M., see Galletti, F. (195) 125
Dannies, P.S., see Pachter, J.A. (195) 373 Gordon, I., see Speiser, Z. (195) 75
DeBartolomeis, A., see Barone, P. (195) 157 Grabowska-Andén, M., see Liljequist, S. (195) 55
De Beurme, F.A., see Lefebvre, R.A. (195) 131 Grassi, A., Ippen, J.. Bruno, M. and Thomas, G.
Dembinski, A., see Konturek, S.J. (195) 347 BAY P 1455, a thiazolylaminobenzimidazole derivative with gas-
De Souza, E.B., see Weissman, A.D. (195) 163 troprotective properties in the rat (195) 251
Downie, J.W., Espey, M.J. and Gajewski, J.B. Guilbaud, G., see Kayser, V. (195) 37
a,-Adrenoceptors not imidazole receptors mediate depression of a
sacral spinal reflex in the cat (195) 301 Hasegawa, J., see Hisatome, I. (195) 381
Dretchen, K.L., see Fleming, N.W. (195) 85 Hekking, J.W.M., see Le Noble, F.A.C. (195) 305
418
Henderson, T.R., see Fleming, N.W. (195) 85 MacLeod, R.M., see Judd, A.M. (195) 101
Hidaka, H., see Seto, M. (195) 267 Maisonneuve, I.M., see Glick, S.D. (195) 341
Hisatome, I., Ishiko, R., Tanaka, Y., Kosaka, H., Hasegawa, J., Majka, J., see Konturek, S.J. (195) 347
Yoshida, A., Kotake, H., Mashiba, H. and Arita, M. Mantymaa, P., see Pitkanen, M. (195) 307
Trimetazidine inhibits Na*,K*-ATPase activity, and overdrive Marin, C., Parashos, S.A. and Chase, T.N.
hyperpolarization in guinea-pig ventricular muscles (195) 381 Effect of G; protein ADP-ribosylation induced by pertussis toxin
Humpel, C., Saria, A. and Regoli, D. on dopamine-mediated behaviors (195) 19
Injection of tachykinins and selective neurokinin receptor ligands Mashiba, H., see Hisatome, I. (195) 381
into the substantia nigra reticulata increases striatal dopamine and Massi, M., Sajia, A., Polidori, C., Perfumi, M., Costa, G. and
5-hydroxytryptamine metabolism (195) 107 Melchiorre, C.
The release of atrial natriuretic factor induced by central carbachol
Ignarro, L.J., see Ross, G. (195) 291 injection may be mediated by muscarinic M, receptors (195) 245
Ippen, J., see Grassi, A. (195) 251 Massi, M., see Polidori, C. (195) 139
Ishihara, S.-i., see Nabeshima, T. (195) 285 Masuda, Y., Arakawa, C., Yamashita, T., Miyajima, M., Shigenobu,
Ishiko, R., see Hisatome, I. (195) 381 K., Kasuya, Y. and Tanaka, S.
Potassium channel opening properties of a novel compound, NIP-
Judd, A.M. and MacLeod, R.M.
121, cromakalim and nicorandil in rat aorta and portal vein (195)
Dopamine receptor and adrenoceptor agonists inhibit prolactin
323
release from MMQ cells (195) 101
McKernan, R.M., see Gillard, N.P. (195) 407
Melchiorre, C., see Massi, M. (195) 245
Kameyama, T., see Nabeshima, T. (195) 285
Melchiorre, C., see Polidori, C. (195) 139
Kasuya, Y., see Masuda, Y. (195) 323
Melchiorri, P., Negri, L., Falconieri-Erspamer, G., Severini, C., Corsi,
Kawakami, M., see Nakajima, S. (195) 145
R., Soaje, M., Erspamer, V. and Barra, D.
Kawakami, M., see Toda, N. (195) 175
Structure-activity relationships of the 6-opioid-selective agonists,
Kayser, V., Besson, J.-M. and Guilbaud, G.
deltorphins (195) 201
Effects of the analgesic agent tramadol in normal and arthritic
Miyajima, M., see Masuda, Y. (195) 323
rats: comparison with the effects of different opioids, including
Mulder, A.H., see Van Vliet, B.J. (195) 295
tolerance and cross-tolerance to morphine (195) 37
Muscettola, G., see Barone, P. (195) 157
Kobayashi, I., see Shimizu, H. (195) 281
Mutschler, E., see Feifel, R. (195) 115
Kobayashi, T., see Nagasaki, M. (195) 317
Kodama, N., see Toda, N. (195) 175 Nabeshima, T., Tohyama, K., Ishihara, S.-i. and Kameyama, T.
Koide, T., see Aono, J. (195) 225 Involvement of the cholinergic neuronal system and _ benzodi-
Konturek, S.J., Brzozowski, T., Drozdowicz, D., Krzyzek, E., Garlicki, azepine receptors in alcohol-induced amnesia (195) 285
J., Majka, J., Dembinski, A., Stachura, J. and Amon, I. Nagasaki, M., Kobayashi, T. and Tamaki, H.
Nocloprost, a unique prostaglandin E, analog with local gastro- Effects of trimebutine on cytosolic Ca?* and force transitions in
protective and ulcer-healing activity (195) 347 intestinal smooth muscle (195) 317
Kosaka, H., see Hisatome, I. (195) 381 Nakajima, S., Kawakami, M. and Ueda, M.
Kotake, H., see Hisatome, I. (195) 381 12-Deoxyphorbol 13-isobutyrate contracts isolated rat thoracic
Krueger, C., see Zhang, H. (195) 27 arteries (195) 145
Krzyzek, E., see Konturek, S.J. (195) 347 Nambi, P., Pullen, M., Wu, H.-L. and Brooks, D.P.
Increase in renal phorbol ester receptors in rats with cyclosporine
Lacey, G., see Giovannini, M.G. (195) 47 A-induced nephrotoxicity (195) 167
Lambrecht, G., see Feifel, R. (195) 115 Negri, L., see Melchiorri, P. (195) 201
Lang, F., see WOll, E. (195) 399 Nistri, A., see Giovannini, M.G. (195) 47
Law, G.J., see Pachter, J.A. (195) 373 Nomikos, G.G., Damsma, G., Wenkstern, D. and Fibiger, H.C.
Lee, N.M., see Roy, S. (195) 359 Chronic desipramine enhances amphetamine-induced increases in
Lefebvre, R.A., De Beurme, F.A. and Sas, S. interstitial concentrations of dopamine in the nucleus accumbens
Relaxant effect of capsaicin in the rat gastric fundus (195) 131 (195) 63
Le Noble, F.A.C., Hekking, J.W.M., Van Straaten, H.W.M., Slaaf, Noronha-Blob, L., see Lowe, V.C. (195) 273
D.W. and Struyker Boudier, H.A.J.
Ossowska, K., see Liljequist, S. (195) 55
Angiotensin II stimulates angiogenesis in the chorio-allantoic
Pachter, J.A., Law, G.J. and Dannies, P.S.
membrane of the chick embryo (195) 305
Li, Y. and Duckles, S.P. Ca** channel agonists enhance thyrotropin-releasing hormone-in-
Differential effects of neuropeptide Y and opioids on neurogenic duced inositol phosphates and prolactin secretion (195) 373
responses of the perfused rat mesentery (195) 365 Palma, V., see Barone, P. (195) 157
Liljequist, S., Ossowska, K., Grabowska-Andén, M. and Andén, N.-E. Palmer, J.M., see Christofi, F.L. (195) 333
Effect of the NMDA receptor antagonist, MK-801, on locomotor Parashos, S.A., see Marin, C. (195) 19
activity and on the metabolism of dopamine in various brain areas Paulmichl, M., see WOll, E. (195) 399
of mice (195) 55 Pechnick, R.N., see Vargas, H.M. (195) 151
Loctin, F., see Girod, R. (195) 1 Pepeu, G., see Giovannini, M.G. (195) 47
Loh, H.H., see Roy, S. (195) 359 Perfumi, M., see Massi, M. (195) 245
Long, J.P., see Bhattacharyya, B.J. (195) 171 Perfumi, M., see Polidori, C. (195) 139
Long, S.K., see Siarey, R.J. (195) 241 Petersen, E.N.
Lowe, V.C. and Noronha-Blob, L. Selective protection by adenosine receptor agonists against
Effect of extracellular Ca?* on cholinergic, KCl and phorbol DMCM-induced seizures (195) 261
ester-mediated phosphoinositide turnover and guinea pig urinary Pfeilschifter, J.
bladder contraction (195) 273 Anti-inflammatory steroids inhibit cytokine induction of nitric
oxide synthase in rat renal mesangial cells (195) 179
Pitkanen, M., Mantymaa, P. and Ruskoaho, H. Sokoll, M.D., see Bhattacharyya, B.J. (195) 171
Staurosporine, a protein kinase C inhibitor, inhibits atrial Speiser, Z., Gordon, I., Rehavi, M. and Gitter, S.
natriuretic peptide secretion induced by sarafotoxin, endothelin Behavioral and biochemical studies in rats following prenatal
and phorbol ester (195) 307 treatment with B-adrenoceptor antagonists (195) 75
Polidori, C., Pompei, P.L., Perfumi, M., Melchiorre, C. and Massi, M. Stachura, J., see Konturek, S.J. (195) 347
Natriuresis, kaliuresis and antidiuresis induced by central Steindorf, S., see Glick, S.D. (195) 341
carbachol injection are mediated by muscarinic M, receptors (195) Stockbridge, N., see Zhang, H. (195) 27
139 Strohmann, C., see Feifel, R. (195) 115
Polidori, C., see Massi, M. (195) 245 Struyker Boudier, H.A.J., see Le Noble, F.A.C. (195) 305
Pompei, P.L., see Polidori, C. (195) 139 Sugawa, M., see Aono, J. (195) 225
Pullen, M., see Nambi, P. (195) 167 Suzuki, Y.
Contraction and prostaglandin biosynthesis by myometrium from
Quirk, K., see Gillard, N.P. (195) 407
non-pregnant and pregnant rabbits in response to adenosine 5’-tri-
Ragan, C.I., see Gillard, N.P. (195) 407
phosphate (195) 93
Ramakrishnan, S., see Roy, S. (195) 359
Regoli, D., see Humpel, C. (195) 107 Tacke, R., see Feifel, R. (195) 115
Rehavi, M., see Speiser, Z. (195) 75 Takato, M., see Aono, J. (195) 225
Reis, D.J., see Gomez, R.E. (195) 181 Tamaki, H., see Nagasaki, M. (195) 317
Richards, M.H. Tanaka, S., see Masuda, Y. (195) 323
Effects of cyproheptadine and pizotifen on central muscarinic Tanaka, S., see Shikada, K.-1. (195) 389
receptors (195) 403 Tanaka, Y., see Hisatome, I. (195) 381
Roberts, F.F., see Barnes, J.C. (195) 233 Tedeschi, E., see Barone, P. (195) 157
Rodrigues de Miranda, J.F., see Feifel, R. (195) 115 Thomas, G., see Grassi, A. (195) 251
Ross, G., Chaudhuri, G., Ignarro, L.J. and Chyu, K.-Y. Toda, N., Kawakami, M. and Kodama, N.
Acetylcholine vasodilation of resistance vessels in vivo may not Prevention by nicardipine of dog basilar artery spasm caused by
entirely depend on newly synthesized nitric oxide (195) 291 oxyhemoglobin in vivo and in vitro (195) 175
Rossman, K., see Glick, $.D. (195) 341 Tohyama, K., see Nabeshima, T. (195) 285
Roy, S., Ramakrishnan, S., Loh, H.H. and Lee, N.M. Triggle, D.J., see Galletti, F. (195) 125
Chronic morphine treatment selectively suppresses macrophage Tsocas, A., see Sautereau, D. (195) 217
colony formation in bone marrow (195) 359
Rozé, C., see Sautereau, D. (195) 217 Ueda, M., see Nakajima, S. (195) 145
Ruskoaho, H., see Pitkanen, M. (195) 307 Uehara, Y., see Shimizu, H. (195) 281
Rutledge, A., see Galletti, F. (195) 125
Ruuls, S.R., see Van Vliet, B.J. (195) 295 Van Straaten, H.W.M., see Le Noble, F.A.C. (195) 305
Van Vliet, B.J., Ruuls, S.R., Drukarch, B., Mulder, A.H. and Schof-
Sajia, A., see Massi, M. (195) 245
felmeer, A.N.M.
Saltarelli, M.D., see Yamada, K. (195) 395
B-Adrenoceptor-sensitive adenylate cyclase is inhibited by activa-
Saria, A., see Humpel, C. (195) 107
tion of u-opioid receptors in rat striatal neurons (195) 295
Sas, S., see Lefebvre, R.A. (195) 131
Vargas, H.M. and Pechnick, R.N.
Sasaki, Y., see Seto, M. (195) 267
Binding affinity and antimuscarinic activity of o and phencycli-
Sasaki, Y., see Seto, M. (195) 267
dine receptor ligands (195) 151
Sautereau, D., Chicau-Chovet, M., Tsocas, A. and Rozé, C.
Virtanen, R., see Savola, J.-M. (195) 193
Central and peripheral effects of prostaglandin E, and enprostil
on gastric acid secretion in the rat (195) 217
Weir, B., see Zhang, H. (195) 27
Savola, J.-M. and Virtanen, R.
Weissman, A.D. and De Souza, E.B.
Central a,-adrenoceptors are highly stereoselective for dexmede-
Chronic treatment of rats with the specific o ligand D-pentazocine
tomidine, the dextro enantiomer of medetomidine (195) 193
fails to modulate dopamine D, and o binding in brain (195) 163
Schoffelmeer, A.N.M., see Van Vliet, B.J. (195) 295
Wenkstern, D., see Nomikos, G.G. (195) 63
Seto, M., Sasaki, Y., Sasaki, Y. and Hidaka, H.
Wheeler-Aceto, H. and Cowan, A.
Effects of HA1077, a protein kinase inhibitor, on myosin phos-
Buprenorphine and morphine cause antinociception by different
phorylation and tension in smooth muscle (195) 267
transduction mechanisms (195) 411
Severini, C., see Melchiorri, P. (195) 201
W6OIll, E., Paulmichl, M., Lang, F. and Glossmann, H.
Shigenobu, K., see Masuda, Y. (195) 323
Effect of a-adrenoceptor agonists on cell membrane potential in
Shikada, K.-i., Yamamoto, A. and Tanaka, S. renal epitheloid Madin Darby canine kidney cells (195) 399
Effects of phosphodiesterase inhibitors on vasoactive intestinal
Wood, J.D., see Christofi, F.L. (195) 333
peptide-induced relaxation of isolated guinea-pig trachea (195) 389
Wu, H.-L., see Nambi, P. (195) 167
Shimizu, H., Uehara, Y., Shimomura, Y. and Kobayashi, I.
Central administration of ibuprofen failed to block the anorexia Yamada, K., Saltarelli, M.D. and Coyle, J.T.
induced by interleukin-1 (195) 281 (?H]Hemicholinium-3 binding in rats with status epilepticus in-
Shimomura, Y., see Shimizu, H. (195) 281 duced by lithium chloride and pilocarpine (195) 395
Siarey, R.J., Long, S.K. and Evans, R.H. Yamamoto, A., see Shikada, K.-1. (195) 389
Potentiation of synaptic reflexes by D-serine in the rat spinal cord Yamashita, T., see Masuda, Y. (195) 323
in vitro (195) 241 Yoshida, A., see Hisatome, I. (195) 381
Slaaf, D.W., see Le Noble, F.A.C. (195) 305
Snyder, D.W., Cho, H.L. and Gilmore, J. Zhang, H., Stockbridge, N., Weir, B., Krueger, C. and Cook, D.
Endogenously formed leukotriene C, activates LTC, receptors in Glibenclamide relaxes vascular smooth muscle constriction pro-
guinea pig tracheal strips (195) 209 duced by prostaglandin F,, (195) 27
Soaje, M., see Melchiorri, P. (195) 201 Zheng, W., see Galletti, F. (195) 125

European Journal of Pharmacology, 195 (1991) 421-430
© 1991 Elsevier Science Publishers B.V. 0014-/2919 /9$039.5 0
Key word index
Acetylcholine a,-Adrenoceptors
Ileum (guinea-pig); Muscarinic receptors; N-Methylscopolamine; Rilmenidine; Oxazoline; Imidazole receptors; Medulla (rostral
Phencyclidine; Phosphatidylinositol; o Receptors (Vargas, H.M. (195) ventrolateral); Arterial pressure (Gomez, R.E. (195) 181)
151)
8-Adrenoceptors
EDRF (endothelium-derived relaxing factor); Blood flow; Nitric Opioid receptors; Adenylate cyclase; Striatal neurons (Van Vliet, B.J.
oxide; (Cat) (Ross, G. (195) 291) (195) 295)
[*H]Hemicholinium-3; Choline uptake (high-affinity); Pilocarpine; 8-Adrenoceptors (central)
Lithium chloride; Phospholipase A, (Yamada, K. (195) 395) Pregnancy; 6-Adrenoceptor antagonists; Offspring behaviour; Hyper-
activity; Active avoidance; Acetylcholine receptors (central) (Speiser,
Acetylcholine receptors (central) Z. (195) 75)
Pregnancy; £-Adrenoceptor antagonists; Offspring behaviour; Hyper-
Amlodipine
activity; Active avoidance; $-Adrenoceptors (central) (Speiser, Z.
Ca?*; Ca** channels; Ca** channel antagonists; 1,4-Dihydropyri-
(195) 75)
dines; Nifedipine; Tiamdipine (Galletti, F. (195) 125)
Acetylcholine release
cAMP
Vesamicol (AH5183); Synaptic transmission; Anaesthetics (local)
Dopamine receptor interactions; Pertussis toxin; Rotational be-
(Girod, R. (195) 1)
haviour (Marin, C. (195) 19)
Acivicin
Prolactin; Dopamine receptors; Adrenoceptors (Judd, A.M. (195)
Leukotrienes; Trachea (guinea-pig); ICI 204,219; LY 171883; Smooth
101)
muscle (airway) (Snyder, D.W. (195) 209)
Amphetamine
Active avoidance
Desipramine; Dopamine; Microdialysis; Nucleus accumbens; Stria-
Pregnancy; B-Adrenoceptor antagonists; Offspring behaviour; Hyper-
tum; Apomorphine (Nomikos, G.G. (195) 63)
activity; Acetylcholine receptors (central); B-Adrenoceptors (central)
(Speiser, Z. (195) 75)
Anaesthetics (local)
Vesamicol (AH5183); Synaptic transmission; Acetylcholine release
Adenosine
(Girod, R. (195) 1)
DMCM (methyl 6,7-dimethoxy-4-ethyl-8-carboline-3-carboxylate);
Seizures; Benzodiazepine receptors; GABA receptors; I-Phenylisopro-
Analgesics
pyladenosine; 2-Chloroadenosine; Cyclohexyladenosine; Pentylene-
a-Adrenoceptors; a,-Adrenoceptor agonists; Sedatives; Mydriatics;
tetrazol; Bicuculline; (Mouse) (Petersen, E.N. (195) 261)
Cardiovascular drugs (Savola, J.-M. (195) 193)
Adenylate cyclase
ANF (atrial natriuretic factor)
Opioid receptors; B-Adrenoceptors; Striatal neurons (Van Vliet, B.J. Carbachol; Muscarinic receptor subtypes; Muscarinic receptor
(195) 295)
antagonists (Massi, M. (195) 245)
a,-Adrenoceptor agonists Angiogenesis
a-Adrenoceptors; Sedatives; Analgesics; Mydriatics; Cardiovascular Angiotensin II; Hypertension; Chorio-allantoic membrane; Blood
drugs (Savola, J.-M. (195) 193) vessels (Le Noble, F.A.C. (195) 305)
Angiotensin II
8-Adrenoceptor antagonists
Angiogenesis; Hypertension; Chorio-allantoic membrane; Blood ves-
Pregnancy; Offspring behaviour; Hyperactivity; Active avoidance;
sels (Le Noble, F.A.C. (195) 305)
Acetylcholine receptors (central); B-Adrenoceptors (central) (Speiser,
Z. (195) 75)
ANP (atrial natriuretic polypeptide)
Protein kinase C; Sarafotoxin; Endothelin; Phorbol ester; Stauro-
Adrenoceptors
sporine (Pitkanen, M. (195) 307)
Prolactin; Dopamine receptors; cAMP (Judd, A.M. (195) 101)
Antidiuresis
Gastric secretion; Prostaglandins; Prostaglandin E,; Enprostil; (In- Carbachol; Muscarinic receptor subtypes; Muscarinic receptor
jections: intracerebroventricular) (Sautereau, D. (195) 217)
antagonists; Natriuresis; Kaliuresis (Polidori, C. (195) 139)
a-Adrenoceptors Antinociception
a,-Adrenoceptor agonists; Sedatives; Analgesics; Mydriatics; Cardio- Paw pressure; Arthritic rats; Tramadol; Morphine; Buprenorphine;
vascular drugs (Savola, J.-M. (195) 193) Nalbuphine; Naloxone; Normal rats (Kayser, V. (195) 37)
422
Antiulcer drugs Blood vessels
Ulcer models (experimental); Indomethacin; Stress; Cysteamine; Angiogenesis; Angiotensin II; Hypertension; Chorio-allantoic mem-
Ethanol; Prostaglandins; Gastric acid secretion (Grassi, A. (195) 251) brane (Le Noble, F.A.C. (195) 305)
Aorta (rat) Body weight
K* channel openers; NIP-121; Cromakalim; Nicorandil; Portal vein Ibuprofen; Interleukin; Food intake; (Rat) (Shimizu, H. (195) 281)
(rat) (Masuda, Y. (195) 323)
Bone marrow
Apomorphine Morphine; £-Endorphin; Colony stimulating factor (Roy, S. (195)
Desipramine; Dopamine; Microdialysis; Nucleus accumbens; Stria- 359)
tum; Amphetamine (Nomikos, G.G. (195) 63)
Buprenorphine
Arterial pressure Antinociception; Paw pressure; Arthritic rats; Tramadol; Morphine;
Rilmenidine; Oxazoline; a -Adrenoceptors; Imidazole receptors; Nalbuphine; Naloxone; Normal rats (Kayser, V. (195) 37)
Medulla (rostral ventrolateral) (Gomez, R.E. (195) 181)
BY-1949
Arthritic rats Platelet aggregation; Cyclic nucleotides; Nitric oxide (Aono, J. (195)
Antinociception; Paw pressure; Tramadol; Morphine; Buprenorphine;
Nalbuphine; Naloxone; Normal rats (Kayser, V. (195) 37)
Aspartate channels; Ca?* channel antagonists; 1,4-Dihydropyridines;
Glutamate; Thyrotropin-releasing hormone (TRH); Spinal cord; Ex-
Nifedipine; Tiamdipine; Amlodipine (Galletti, F. (195) 125)
citatory amino acids; Tetrodotoxin (Giovannini, M.G. (195) 47)
Ca?* -calmodulin
ATP (adenosine 5’ -triphosphate)
12-Deoxyphorbol 13-isobutyrate; Protein kinase C; Thoracic artery
Myometrial contractions; Prostaglandins; Purinoceptors (Suzuki, Y.
(rat); Contraction; Ca?* levels (intracellular) (Nakajima, S. (195)
(195) 93)
145)
Autonomic ganglia
Ca”* channel antagonists
Enteric nervous system; Myenteric plexus; Small intestine; Muscarinic
Ca?*; Ca** channels; 1,4-Dihydropyridines; Nifedipine; Tiamdipine;
receptors; Telenzepine (Christofi, F.L. (195) 333)
Amlodipine (Galletti, F. (195) 125)
Benzodiazepine binding sites
Ca** channels
['*° I]lodoclonazepam; GABA, receptors (Gillard, N.P. (195) 407)
Ca**; Ca** channel antagonists; 1,4-Dihydropyridines; Nifedipine;
Tiamdipine; Amlodipine (Galletti, F. (195) 125)
Benzodiazepine receptors
Adenosine; DMCM (methyl 6,7-dimethoxy-4-ethyl-B-carboline-3-
Pituitary (anterior); Dihydropyridine; Inositol trisphosphate; Nimo-
carboxylate); Seizures; GABA receptors; 1-Phenylisopropyladenosine;
dipine; Thyrotropin-releasing hormone (TRH) (Pachter, J.A. (195)
2-Chloroadenosine; Cyclohexyladenosine; Pentylenetetrazol; Bicucul-
373)
line; (Mouse) (Petersen, E.N. (195) 261)
Ca** (intracellular)
Benzodiazepines
Membrane potential; Epinephrine; K* channels (WOll, E. (195) 399)
Hypnotics; Sleep; REM (rapid eye movement) sleep; EEG spectral
analysis; Slow-wave activity (Borbély, A.A. (195) 11)
Ca** levels (intracellular)
12-Deoxyphorbol 13-isobutyrate; Protein kinase C; Thoracic artery
Bicuculline
(rat); Contraction; Ca? *-calmodulin (Nakajima, S. (195) 145)
Adenosine; DMCM (methyl 6,7-dimethoxy-4-ethyl-8-carboline-3-
carboxylate); Seizures; Benzodiazepine receptors; GABA receptors;
Capsaicin
l-Phenylisopropyladenosine; 2-Chloroadenosine; Cyclohexyladeno-
Gastric fundus (rat); Vasoactive intestinal polypeptide (VIP); CGRP
sine; Pentylenetetrazol; (Mouse) (Petersen, E.N. (195) 261)
(calcitonin gene-related peptide) (Lefebvre, R.A. (195) 131)
Ethanol; Chlordiazepoxide; GABA, receptors; Physostigmine;
Cholinergic neuronal system (Nabeshima, T. (195) 285) Mesentery (rat); CGRP (calcitonin gene-related peptide); Neuro-
peptide Y; DAMGO_ [D-Ala*,N-Me-Phe*,Gly°-ol]enkephalin);
DPDPE ({D-Pen?,D-Pen°]enkephalin); Ethylketocyclazocine; In-
Bladder detrusor muscle
Phosphoinositide breakdown; Phorbol esters; Ca** stores; High K* domethacin (Li, Y. (195) 365)
stimulation; Muscarinic acetylcholine receptors (Lowe, V.C. (195)
273) Carbachol
Muscarinic receptor subtypes; Muscarinic receptor antagonists; Anti-
Blood flow diuresis; Natriuresis; Kaliuresis (Polidori, C. (195) 139)
EDRF (endothelium-derived relaxing factor); Acetylcholine; Nitric
oxide; (Cat) (Ross, G. (195) 291) Muscarinic receptor subtypes; Muscarinic receptor antagonists; ANF
(atrial natriuretic factor) (Massi, M. (195) 245)
Blood pressure
Theta rhythm; Muscarinic receptor agonists; Muscarinic receptor Cardiovascular drugs
antagonists; Muscarinic receptor subtypes; (Rat) (Barnes, J.C. (195) a-Adrenoceptors; a,-Adrenoceptor agonists; Sedatives; Analgesics;
233) Mydriatics (Savola, J.-M. (195) 193)
Ca?* stores Cyclohexyladenosine
Phosphoinositide breakdown; Phorbol esters; High K* stimulation; Adenosine; DMCM (methyl 6,7-dimethoxy-4-ethyl-8-carboline-3-
Bladder detrusor muscle; Muscarinic acetylcholine receptors (Lowe, carboxylate); Seizures; Benzodiazepine receptors; GABA receptors;
V.C. (195) 273) l-Phenylisopropyladenosine; 2-Chloroadenosine; Pentylenetetrazol;
Bicuculline; (Mouse) (Petersen, E.N. (195) 261)
Cerebral vasospasm
Nicardipine; Oxyhemoglobin (Toda, N. (195) 175) Cyclosporine A
Kidney; Protein kinase C; Phorbol ester receptor (Nambi, P. (195)
CGRP (calcitonin gene-related peptide) 167)
Capsaicin; Gastric fundus (rat); Vasoactive intestinal polypeptide
(VIP) (Lefebvre, R.A. (195) 131) Cyproheptadine
Muscarinic receptors; Pizotifen (Richards, M.H. (195) 403)
Mesentery (rat); Capsaicin; Neuropeptide Y; DAMGO [D-Ala’,N-
Me-Phe*,Gly°-olJjenkephalin); DPDPE ({D-Pen?,D-Pen? Jenkephalin); Cysteamine
Ethylketocyclazocine; Indomethacin (Li, Y. (195) 365) Antiulcer drugs; Ulcer models (experimental); Indomethacin; Stress;
Ethanol; Prostaglandins; Gastric acid secretion (Grassi, A. (195) 251)
Chlordiazepoxide
Cytoprotection
Ethanol; Bicuculline; GABA, receptors; Physostigmine; Cholinergic
Stomach; Peptic ulcer; Prostaglandin (Konturek, S.J. (195) 347)
neuronal system (Nabeshima, T. (195) 285)
DAMGO |[D-Ala”,N-Me-Phe*,Gly °-ol]enkephalin)
2-Chloroadenosine
Adenosine; DMCM (methyl 6,7-dimethoxy-4-ethyl-$-carboline-3- Mesentery (rat); Capsaicin; CGRP (calcitonin gene-related peptide);
Neuropeptide Y; DPDPE ({D-Pen*,D-Pen’ Jenkephalin); Ethylketo-
carboxylate); Seizures; Benzodiazepine receptors; GABA receptors;
l-Phenylisopropyladenosine; Cyclohexyladenosine; Pentylenetetrazol; cyclazocine; Indomethacin (Li, Y. (195) 365)
Bicuculline; (Mouse) (Petersen, E.N. (195) 261)
Deltorphins
Synthetic peptides; Receptor binding assay; Vas deferens assay
Cholinergic neuronal system
(mouse); 5-Opioid receptors (selectivity for) (Melchiorri, P. (195) 201)
Ethanol; Chlordiazepoxide; Bicuculline; GABA, receptors; Physo-
stigmine (Nabeshima, T. (195) 285)
12-Deoxyphorbol 13-isobutyrate
Protein kinase C; Thoracic artery (rat); Contraction; Ca?* levels
Choline uptake (high-affinity)
(intracellular); Ca? *-calmodulin (Nakajima, S. (195) 145)
[?H]Hemicholinium-3; Acetylcholine; Pilocarpine; Lithium chloride;
Phospholipase A, (Yamada, K. (195) 395)
Desipramine
Dopamine; Microdialysis; Nucleus accumbens; Striatum; Ampheta-
Chorio-allantoic membrane
mine; Apomorphine (Nomikos, G.G. (195) 63)
Angiogenesis; Angiotensin II; Hypertension; Blood vessels (Le Noble,
F.A.C. (195) 305)
Dihydropyridine
Pituitary (anterior); Ca?* channels; Inositol trisphosphate; Nimodi-
Clonidine
pine; Thyrotropin-releasing hormone (TRH) (Pachter, J.A. (195) 373)
Guanabenz; Reflex; Spinal cord; Urethra; Sphincter (Downie, J.W.
(195) 301)
1,4-Dihydropyridines
Ca**; Ca** channels; Ca** channel antagonists; Nifedipine;
CNQX (6-cyano-7-nitroquinoxaline-2,3-dione)
Tiamdipine; Amlodipine (Galletti, F. (195) 125)
D-Serine; Spinal cord; (Electrophysiology) (Siarey, R.J. (195) 241)
Diphosphorylation
Colony stimulating factor
Smooth muscle; MLC,, (myosin-light chain); Monophosphorylation;
Morphine; £-Endorphin; Bone marrow (Roy, S. (195) 359)
Protein kinase inhibitor; HA-1077 (Seto, M. (195) 267)
Contraction DMCM (methyl! 6,7-dimethoxy-4-ethyl- 8 -carboline-3-carboxylate)
12-Deoxyphorbol 13-isobutyrate; Protein kinase C; Thoracic artery Adenosine; Seizures; Benzodiazepine receptors; GABA receptors; 1-
(rat); Ca?* levels (intracellular); Ca? *-calmodulin (Nakajima, S. (195) Phenylisopropyladenosine; 2-Chloroadenosine; Cyclohexyladenosine;
145)
Pentylenetetrazol; Bicuculline; (Mouse) (Petersen, E.N. (195) 261)
Trimebutine; Fura-2; [Ca?*], mobilization; Taenia caecum (guinea- DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane)
pig) (Nagasaki, M. (195) 317) Neuromuscular transmission; 5-HT receptor agonists; 5-HT,-like re-
ceptor antagonists (Bhattacharyya, B.J. (195) 171)
Convulsions
Lithium-pilocarpine; Dopamine receptors; Dopamine _ receptor Dopamine
antagonists (Barone, P. (195) 157) Desipramine; Microdialysis; Nucleus accumbens; Striatum; Amphet-
amine; Apomorphine (Nomikos, G.G. (195) 63)
Cromakalim
K* channel openers; NIP-121; Nicorandil; Aorta (rat); Portal vein Tachykinins; Striatum; Substantia nigra; 5-HT (5-hydroxytryptamine,
(rat) (Masuda, Y. (195) 323) serotonin) (Humpel, C. (195) 107)
Cyclic nucleotides o-Receptors; Phencyclidine; Psychosis; Haloperidol; YM-09151-2
BY-1949; Platelet aggregation; Nitric oxide (Aono, J. (195) 225) (Weissman, A.D. (195) 163)
424
Dopamine metabolism Excitatory amino acids
MK-801; NMDA receptors; Striatum; Limbic forebrain; Hippocam- Glutamate; Aspartate; Thyrotropin-releasing hormone (TRH); Spinal
pus; NMRI mouse (Liljequist, S. (195) 55) cord; Tetrodotoxin (Giovannini, M.G. (195) 47)
Dopamine receptor antagonists Food intake
Lithium-pilocarpine; Convulsions; Dopamine receptors (Barone, P. Ibuprofen; Interleukin; Body weight; (Rat) (Shimizu, H. (195) 281)
(195) 157)
Fura-2
Dopamine receptor interactions
Trimebutine; [Ca?*]; mobilization; Taenia caecum (guinea-pig);
Pertussis toxin; cAMP; Rotational behaviour (Marin, C. (195) 19)
Contraction (Nagasaki, M. (195) 317)
Dopamine receptors
GABA receptors
Prolactin; Adrenoceptors; cAMP (Judd, A.M. (195) 101)
Adenosine; DMCM (methyl 6,7-dimethoxy-4-ethyl-8-carboline-3-
Lithium-pilocarpine; Convulsions; Dopamine receptor antagonists carboxylate); Seizures; Benzodiazepine receptors; 1-Phenylisopro-
pyladenosine; 2-Chloroadenosine; Cyclohexyladenosine; Pentylene-
(Barone, P. (195) 157)
tetrazol; Bicuculline; (Mouse) (Petersen, E.N. (195) 261)
DPDPE (|D-Pen”,D-Pem |enkephalin)
Mesentery (rat); Capsaicin; CGRP (calcitonin gene-related peptide); GABA , receptors
Neuropeptide Y; DAMGO [D-Ala?,N-Me-Phe*,Gly°-ol]enkephalin); Ethanol; Chlordiazepoxide; Bicuculline; Physostigmine; Cholinergic
Ethylketocyclazocine; Indomethacin (Li, Y. (195) 365) neuronal system (Nabeshima, T. (195) 285)
Drug self-administration
['?°I]lodoclonazepam; Benzodiazepine binding sites (Gillard, N.P.
Ibogaine; Morphine (Glick, S.D. (195) 341)
(195) 407)
EDRF (endothelium-derived relaxing factor)
Gastric acid secretion
Acetylcholine; Blood flow; Nitric oxide; (Cat) (Ross, G. (195) 291)
Antiulcer drugs; Ulcer models (experimental); Indomethacin; Stress;
Cysteamine; Ethanol; Prostaglandins (Grassi, A. (195) 251)
EEG spectral analysis
Benzodiazepines; Hypnotics; Sleep; REM (rapid eye movement) sleep;
Slow-wave activity (Borbély, A.A. (195) 11) Gastric fundus (rat)
Capsaicin; Vasoactive intestinal polypeptide (VIP); CGRP (calcitonin
8-Endorphin gene-related peptide) (Lefebvre, R.A. (195) 131)
Morphine; Bone marrow; Colony stimulating factor (Roy, S. (195)
359) Gastric secretion
Prostaglandins; Prostaglandin E,; Enprostil; Adrenoceptors; (Injec-
Endothelin tions: intracerebroventricular) (Sautereau, D. (195) 217)
ANP (atrial natriuretic polypeptide); Protein kinase C; Sarafotoxin;
Phorbol ester; Staurosporine (Pitkanen, M. (195) 307) Glutamate
Aspartate; Thyrotropin-releasing hormone (TRH); Spinal cord; Exci-
Endothelium
tatory amino acids; Tetrodotoxin (Giovannini, M.G. (195) 47)
Glyceryl trinitrate; Papaverine; Methylene blue; Smooth muscle
(vascular); Isometric tension recording (Zhang, H. (195) 27)
Glyceryl trinitrate
Papaverine; Methylene blue; Smooth muscle (vascular); Endothelium;
Enprostil
Isometric tension recording (Zhang, H. (195) 27)
Gastric secretion; Prostaglandins; Prostaglandin E,; Adrenoceptors;
(Injections: intracerebroventricular) (Sautereau, D. (195) 217)
Guanabenz
Enteric nervous system Clonidine; Reflex; Spinal cord; Urethra; Sphincter (Downie, J.W.
Myenteric plexus; Small intestine; Autonomic ganglia; Muscarinic (195) 301)
receptors; Telenzepine (Christofi, F.L. (195) 333)
HA-1077
Epinephrine
Smooth muscle; MLC,, (myosin-light chain); Monophosphorylation;
Membrane potential; Ca?* (intracellular); K* channels (WOll, E.
Diphosphorylation; Protein kinase inhibitor (Seto, M. (195) 267)
(195) 399)
Ethanol Haloperidol
Antiulcer drugs; Ulcer models (experimental); Indomethacin; Stress; o-Receptors; Phencyclidine; Psychosis; Dopamine; YM-09151-2
Cysteamine; Prostaglandins; Gastric acid secretion (Grassi, A. (195) (Weissman, A.D. (195) 163)
251)
[> H]Hemicholinium-3
Chlordiazepoxide; Bicuculline; GABA, receptors; Physostigmine;
Choline uptake (high-affinity); Acetylcholine; Pilocarpine; Lithium
Cholinergic neuronal system (Nabeshima, T. (195) 285)
chloride; Phospholipase A, (Yamada, K. (195) 395)
Ethylketocyclazocine
Mesentery (rat); Capsaicin; CGRP (calcitonin gene-related peptide); Hexahydro-difenidol analogues
Neuropeptide Y; DAMGO [D-Ala?,N-Me-Phe*,Gly°-olJenkephalin); (7H](+)-Telenzepine; Muscarinic M, receptors; Superior cervical
DPDPE ({D-Pen*,D-Pen® Jenkephalin); Indomethacin (Li, Y. (195) ganglia (calf); Trihexyphenidyl; Hexbutinol; Stereoselectivity (Feifel,
365) R. (195) 115)
Hexbutinol Inositol trisphosphate
[7H]( + )-Telenzepine; Muscarinic M, receptors; Superior cervical Pituitary (anterior); Ca?* channels; Dihydropyridine; Nimodipine;
ganglia (calf); Hexahydro-difenidol analogues; Trihexyphenidyl; Thyrotropin-releasing hormone (TRH) (Pachter, J.A. (195) 373)
Stereoselectivity (Feifel, R. (195) 115)
Interleukin
High K* stimulation Ibuprofen; Food intake; Body weight; (Rat) (Shimizu, H. (195) 281)
Phosphoinositide breakdown; Phorbol esters; Ca?* stores; Bladder
|'?5 1}lodoclonazepam
detrusor muscle; Muscarinic acetylcholine receptors (Lowe, V.C. (195)
273) GABA, receptors; Benzodiazepine binding sites (Gillard, N.P. (195)
407)
Hippocampus
MK-801; NMDA receptors; Dopamine metabolism; Striatum; Limbic Isometric tension recording
forebrain; NMRI mouse (Liljequist, S. (195) 55) Glyceryl trinitrate; Papaverine; Methylene blue; Smooth muscle
(vascular); Endothelium (Zhang, H. (195) 27)
5-HT (5-hydroxytryptamine, serotonin)
Tachykinins; Striatum; Substantia nigra; Dopamine (Humpel, C. Isoproterenol
(195) 107) VIP (vasoactive intestinal polypeptide); Prostaglandin E,; Leukotriene
D,-induced contraction; Phosphodiesterase inhibitors; Trachea (iso-
5-HT, -like receptor antagonists lated, guinea-pig) (Shikada, K.-i. (195) 389)
Neuromuscular transmission; 5-HT receptor agonists; DOI (1-(2,5-di-
Kaliuresis
methoxy-4-iodophenyl)-2-aminopropane) (Bhattacharyya, B.J. (195)
Carbachol; Muscarinic receptor subtypes; Muscarinic receptor
171)
antagonists; Antidiuresis; Natriuresis (Polidori, C. (195) 139)
5-HT receptor agonists
K* channel openers
Neuromuscular transmission; DOI (1-(2,5-dimethoxy-4-iodopheny]l)-
NIP-121; Cromakalim; Nicorandil; Aorta (rat); Portal vein (rat)
2-aminopropane); 5-HT,-like receptor antagonists (Bhattacharyya, B.J.
(Masuda, Y. (195) 323)
(195) 171)
K* channels
Hyperactivity
Membrane potential; Ca** (intracellular); Epinephrine (WOll, E.
Pregnancy; B-Adrenoceptor antagonists; Offspring behaviour; Active
(195) 399)
avoidance; Acetylcholine receptors (central); 8-Adrenoceptors
(central) (Speiser, Z. (195) 75)
Kidney
Cyclosporine A; Protein kinase C; Phorbol ester receptor (Nambi, P.
Hypertension
(195) 167)
Angiogenesis; Angiotensin II; Chorio-allantoic membrane; Blood ves-
sels (Le Noble, F.A.C. (195) 305)
Leukotriene D,-induced contraction
VIP (vasoactive intestinal polypeptide); Isoproterenol; Prostaglandin
Hypnotics
E,; Phosphodiesterase inhibitors; Trachea (isolated, guinea-pig)
Benzodiazepines; Sleep; REM (rapid eye movement) sleep; EEG
(Shikada, K.-i. (195) 389)
spectral analysis; Slow-wave activity (Borbély, A.A. (195) 11)
Leukotrienes
Ibogaine
Trachea (guinea-pig); Acivicin; ICI 204,219; LY 171883; Smooth
Morphine; Drug self-administration (Glick, S.D. (195) 341)
muscle (airway) (Snyder, D.W. (195) 209)
Ibuprofen
Limbic forebrain
Interleukin; Food intake; Body weight; (Rat) (Shimizu, H. (195) 281)
MK-801; NMDA receptors; Dopamine metabolism; Striatum; Hip-
pocampus; NMRI mouse (Liljequist, S. (195) 55)
ICI 204,219
Leukotrienes; Trachea (guinea-pig); Acivicin; LY 171883; Smooth
Lithium chloride
muscle (airway) (Snyder, D.W. (195) 209) [*H]Hemicholinium-3; Choline uptake (high-affinity); Acetylcholine;
Pilocarpine; Phospholipase A, (Yamada, K. (195) 395)
Ileum (guinea-pig)
Acetylcholine; Muscarinic receptors; N-Methylscopolamine; Phen-
Lithium-pilocarpine
cyclidine; Phosphatidylinositol; o Receptors (Vargas, H.M. (195) 151)
Convulsions; Dopamine receptors; Dopamine receptor antagonists
(Barone, P. (195) 157)
Imidazole receptors
Rilmenidine; Oxazoline; a,-Adrenoceptors; Medulla (rostral ventro-
LY 171883
lateral); Arterial pressure (Gomez, R.E. (195) 181)
Leukotrienes; Trachea (guinea-pig); Acivicin; ICI 204,219; Smooth
muscle (airway) (Snyder, D.W. (195) 209)
Indomethacin
Antiulcer drugs; Ulcer models (experimental); Stress; Cysteamine;
Medulla (rostral ventrolateral)
Ethanol; Prostaglandins; Gastric acid secretion (Grassi, A. (195) 251)
Rilmenidine; Oxazoline; a,-Adrenoceptors; Imidazole receptors;
Mesentery (rat); Capsaicin; CGRP (calcitonin gene-related peptide); Arterial pressure (Gomez, R.E. (195) 181)
Neuropeptide Y; DAMGO [D-Ala?,N-Me-Phe*,Gly°-olJenkephalin);
DPDPE ({D-Pen?,D-Pen°]enkephalin); Ethylketocyclazocine (Li, Y. Membrane potential
(195) 365) Ca** (intracellular); Epinephrine; K* channels (W6ll, E. (195) 399)
426
Mesentery (rat) Enteric nervous system; Myenteric plexus; Small intestine; Auto-
Capsaicin; CGRP (calcitonin gene-related peptide); Neuropeptide Y; nomic ganglia; Telenzepine (Christofi, F.L. (195) 333)
DAMGO [D-Ala?,N-Me-Phe4,Gly°®-olJenkephalin); DPDPE ({D-
Pen?,D-Pen” Jenkephalin); Ethylketocyclazocine; Indomethacin (Li, Y. Cyproheptadine; Pizotifen (Richards, M.H. (195) 403)
(195) 365)
Muscarinic M, receptors
Methylene blue [°H](+)-Telenzepine; Superior cervical ganglia (calf); Hexahydro-dif-
Glyceryl trinitrate; Papaverine; Smooth muscle (vascular); Endo- enidol analogues; Trihexyphenidyl; Hexbutinol; Stereoselectivity
thelium; Isometric tension recording (Zhang, H. (195) 27) (Feifel, R. (195) 115)
Muscarinic receptor subtypes
N-Methylscopolamine
Acetylcholine; Ileum (guinea-pig); Muscarinic receptors; Phencycli- Carbachol; Muscarinic receptor antagonists; Antidiuresis; Natriure-
dine; Phosphatidylinositol; o Receptors (Vargas, H.M. (195) 151) sis; Kaliuresis (Polidori, C. (195) 139)
Theta rhythm; Blood pressure; Muscarinic receptor agonists; Musca-
Microdialysis
rinic receptor antagonists; (Rat) (Barnes, J.C. (195) 233)
Desipramine; Dopamine; Nucleus accumbens; Striatum; Ampheta-
mine; Apomorphine (Nomikos, G.G. (195) 63)
Carbachol; Muscarinic receptor antagonists; ANF (atrial natriuretic
factor) (Massi, M. (195) 245)
MK-801
NMDA receptors; Dopamine metabolism; Striatum; Limbic fore-
Mydriatics
brain; Hippocampus; NMRI mouse (Liljequist, S. (195) 55)
a-Adrenoceptors; a,-Adrenoceptor agonists; Sedatives; Analgesics;
Cardiovascular drugs (Savola, J.-M. (195) 193)
MLC,, (myosin-light chain)
Smooth muscle; Monophosphorylation; Diphosphorylation; Protein
Myenteric plexus
kinase inhibitor; HA-1077 (Seto, M. (195) 267)
Enteric nervous system; Small intestine; Autonomic ganglia; Musca-
rinic receptors; Telenzepine (Christofi, F.L. (195) 333)
[Ca?* ], mobilization
Trimebutine; Fura-2; Taenia caecum (guinea-pig); Contraction
Myometrial contractions
(Nagasaki, M. (195) 317)
ATP (adenosine 5’-triphosphate); Prostaglandins; Purinoceptors
(Suzuki, Y. (195) 93)
Monophosphorylation
Smooth muscle; MLC,,. (myosin-light chain); Diphosphorylation; Na*,K t-ATPase
Protein kinase inhibitor; HA-1077 (Seto, M. (195) 267) Overdrive hyperpolarization; Trimetazidine; (Guinea-pig) (Hisatome,
I. (195) 381)
Morphine
Antinociception; Paw pressure; Arthritic rats; Tramadol; Buprenor- Nalbuphine
phine; Nalbuphine; Naloxone; Normal rats (Kayser, V. (195) 37) Antinociception; Paw pressure; Arthritic rats; Tramadol; Morphine;
Buprenorphine; Naloxone; Normal rats (Kayser, V. (195) 37)
Ibogaine; Drug self-administration (Glick, S.D. (195) 341)
Naloxone
B-Endorphin; Bone marrow; Colony stimulating factor (Roy, S. (195) Antinociception; Paw pressure; Arthritic rats; Tramadol; Morphine;
359) Buprenorphine; Nalbuphine; Normal rats (Kayser, V. (195) 37)
Muscarinic acetylcholine receptors Natriuresis
Phosphoinositide breakdown; Phorbol esters; Ca** stores; High K*
Carbachol; Muscarinic receptor subtypes; Muscarinic receptor
stimulation; Bladder detrusor muscle (Lowe, V.C. (195) 273)
antagonists; Antidiuresis; Kaliuresis (Polidori, C. (195) 139)
Muscarinic receptor agonists
Neuromuscular transmission
Theta rhythm; Blood pressure; Muscarinic receptor antagonists;
5-HT receptor agonists; DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-
Muscarinic receptor subtypes; (Rat) (Barnes, J.C. (195) 233)
aminopropane); 5-HT,-like receptor antagonists (Bhattacharyya, B.J.
(195) 171)
Muscarinic receptor antagonists
Carbachol; Muscarinic receptor subtypes; Antidiuresis; Natriuresis; Neuropeptide Y
Kaliuresis (Polidori, C. (195) 139) Mesentery (rat); Capsaicin; CGRP (calcitonin gene-related peptide);
DAMGO [D-Ala?,N-Me-Phe*,Gly°-olljenkephalin); DPDPE ([{D-
Theta rhythm; Blood pressure; Muscarinic receptor agonists; Musca- Pen*,D-Pen® Jenkephalin); Ethylketocyclazocine; Indomethacin (Li, Y.
rinic receptor subtypes; (Rat) (Barnes, J.C. (195) 233) (195) 365)
Carbachol; Muscarinic receptor subtypes; ANF (atrial natriuretic Nicardipine
factor) (Massi, M. (195) 245) Cerebral vasospasm; Oxyhemoglobin (Toda, N. (195) 175)
Muscarinic receptors Nicorandil
Acetylcholine; Ileum (guinea-pig); N-Methylscopolamine; Phencycli- K* channel openers; NIP-121; Cromakalim; Aorta (rat); Portal vein
dine; Phosphatidylinositol; o Receptors (Vargas, H.M. (195) 151) (rat) (Masuda, Y. (195) 323)